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a b s t r a c t
Protein phosphorylation is one of the most important post-translational modiﬁcations regulating var-
ious signaling processes in all known living organisms. In the cell, protein phosphatases and protein
kinases play a dynamic antagonistic role, controlling the phosphorylation state of tyrosine (Tyr), ser-
ine (Ser) and threonine (Thr) side chains of proteins. The reversible phosphorylation modulates protein
function, through initiating conformational changes, which inﬂuences protein complex formation, alter-
ation of enzyme activity and changes in protein stability and subcellular localization. These molecular
changes affect signaling cascades regulating the cell cycle, differentiation, cell–cell and cell–substrate
interactions, cell motility, the immune response, ion-channel and transporter activities, gene transcrip-
tion, mRNA translation, and basic metabolism. In addition to these processes, in unicellular parasites, like
Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp., additional signaling pathways have evolved
to enable the survival of parasites in the changing environment of the vector and host organism. In recent
years the genome of ﬁve trypanosomatid genomes have been sequenced and annotated allowing com-
plete deﬁnition of the composition of the trypanosomatid phosphatomes. The very diverse environments
involved in the different stages of the kinetoplastids’ life cycle might have played a role to develop a set
of trypanosomatid-speciﬁc phosphatases in addition to orthologues of many higher eukaryote protein
phosphatases present in the kinetoplastid phosphatomes. In spite of their well-described phosphatomes,
few trypanosomatid protein phosphatases have been characterized and studied in vivo. The aim of this
review is to give an up to date scope of the research, which has been carried out on trypanosomatid
protein phosphatases.
© 2010 Elsevier B.V. All rights reserved.
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. Introduction
.1. Trypanosomatids and diseases
The members of the Kinetoplastida are ﬂagellated unicellular
rganisms, including extra and intracellular parasites responsible
or severe diseases in humans and animals, as well as vari-
us free-living forms found in soil and aquatic environments.
n this review I will focus on the three most important human
athogens Trypanosoma brucei, Trypanosoma cruzi, and Leishmania
nd their protein phosphatases, since these have available genome
equences and are the most experimentally characterized.
T. brucei and its subspecies are transmitted by tsetse ﬂies (Fig. 1
odiﬁed from Ref. [1]) and cause human African trypanosomiasis
HAT) andnagana in cattle. African sleeping sickness threatens over
0 million people in 36 sub-Saharan African countries, and has an
normouseffect alsoon the livestockandeconomicdevelopmentof
ffected areas. Unlike sleeping sickness, Chagas disease is causedby
he intracellular pathogen,T. cruzi, transmittedbyblood feeding tri-
tomid insects (Fig. 1modiﬁed fromRef. [1]). Thedisease is endemic
hroughout Latin America, where the estimated number of cases is
ig. 1. Combined life cycles of the three Trypanosomatid species in their vertebrate ho
andﬂy (L. major)). The life cycle stages shown for T. brucei in the vertebrate host’s blood:
ransmission. In the tsetse ﬂy vector: the proliferative procyclics in the midgut and epimas
n the salivary gland. T. cruzi: the trypomastigotes invade various cells (including cardia
nfected cells and await for transmission, or infect new cells. In the reduviid bug the pro
olonizing the hindgut. L. major: the proliferative amastigotes invade macrophages, after ﬁ
he proliferating promastigotes are colonizing the midgut and the non-dividing metacycl
he non-dividing forms were boxed in each life cycles. The life cycle stages in the insect ve
ith gradient red to blue colour show transmission of the parasites from the mammals
ertebrate host passage. Based on Ref. [1].. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
around 8–10 million. Pathogens belonging to Leishmania taxon, are
intracellular and transmitted by sandﬂies (Fig. 1 modiﬁed form).
They cause various diseases ranging from self-healing cutaneous
leishmaniasis to severe (and lethal if untreated) visceral leishma-
niasis (also known as kala-azar), a common infectious disease in
Southern Europe, Africa, Asia and the Americas, killing thousands
and debilitating millions of people each year.
The combined number of people infected by kinetoplastid
pathogens is estimated to be over 20 million, resulting in various
health problems and more than 100,000 deaths each year. With
half a billion of people at risk, mostly in the tropical and subtropi-
cal areas of theworld, theseparasites represent an important global
health problem with associated signiﬁcant economic burden [2].
1.2. Bioinformatic analysis of TriTryp genomes and proteomesThe genomes of three kinetoplastid parasites T. brucei [3] T. cruzi
[4] and Leishmania major [5] have been published, followed by a
study of comparative genomics study giving insight into the evo-
lutionary similarities and differences between the L. infantum and
L. braziliensis genomes [6]. These studies enabled the assembly of
st and their transmitting vectors (tsetse ﬂy (T. brucei), reduviid bug (T. cruzi) and
dividing long slender form, and the non-dividing short stumpy form, awaiting for
tigotes in proventriculus and the non-dividing metacyclics, ready for transmission,
c and muscle cells) and transforms into amastigotes which either burst from the
liferating epimastigotes are found in the midgut and the non-dividing metacyclics
lling up the cells burst from the infected cells and await for transmission. In sandﬂy
ics can be found in the proboscis. The proliferative life cycle stages are circled, and
ctors are highlighted in blue, and the vertebrate host stages are in red. Arrowheads
to the insect vector, and arrowheads with blue to red gradient mark the vector to
B. Szöör / Molecular & Biochemical Parasitology 173 (2010) 53–63 55
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pig. 2. Classiﬁcation of serine/threonine speciﬁc (A) and protein tyrosine phospha
hades of boxes denote protein phosphatases belonging the same subfamilies, the p
he TriTryp kinome [7] and phosphatome [8] providing a compila-
ion of kinases andphosphatases encoded in the respective parasite
enomes.
Protein phosphatases remove phosphate groups from various
hosphorylated amino acids. The most predominant phosphory-
ation sites in eukaryotic cells are detected on serine, threonine
nd tyrosine residues. The ﬁrst phosphoproteome analysis of
inetoplastids [9] identiﬁed 491 phosphoproteins in the blood-
tream form of T. brucei, which means 5.5% of the proteins
ere phosphorylated in this life cycle stage, although this is
ery likely a small fraction of the phosphorylated proteins found
n an intact cell. The majority of the identiﬁed proteins were
hosphorylated on Ser or Thr (75 and 21.5% respectively) and
nly 3.5% were Tyr phosphorylated, thereby showing a similar
although slightly reduced percentage of tyrosine-phosphorylated
roteins) phosphorylation pattern described in bacteria (69/22/9%
er/Thr/Tyr) [10]. In vertebrates (HeLa cells) an even lower per-
entage of tyrosine-phosphorylated proteins have been described
86.4/11.8/1.8%) [11] compared to the aforementioned unicellular
rganisms.
.3. Classiﬁcation of protein phosphatases
Protein phosphatases can be classiﬁed into four major groups
ased on catalytic signature motifs and substrate preferences:
hosphoprotein phosphatases (PPPs), metallo-dependent pro-
ein phosphatases (PPMs), aspartate-based phosphatases with a
xDxT/V motif (the members of these three groups are Ser/Thr
peciﬁc phosphatases) and the distinct group of protein tyrosine
hosphatases (PTPs) (Fig. 2A and B and Tables 1 and 2) [12].(B). Protein phosphatases were classiﬁed on the basis of sequence similarity. The
atase groups absent from Trypanosomatidae have been boxed in white.
2. Serine/threonine speciﬁc phosphatases (STPs)
In eukaryotes the majority of proteins (96–99%) are phosphory-
lated on Ser and Thr residues. STPs are responsible for the majority
of dephosphorylation events of these residues in the cell and classi-
ﬁed into three major families based on sequence homology, metal
ion dependence, sensitivity for various inhibitors and catalysis
based mechanisms [13]. The three families of the STPs are: (i) PPPs,
(ii) PPM/PP2C families and (iii) DxDx(S/T) phosphatases (Fig. 2A
and Table 2). The genes encoding the PPPs and PPMs show very
low homology to each other, despite a very similar 3D structure
surrounding the catalytic centre, and form evolutionary distinct
unrelated groups of the Ser/Thr speciﬁc phosphatases [14]. Also,
in contrast to members of PPM family, which do not have regula-
tory subunits, the enzyme activity, substrate speciﬁcity, subcellular
localization of PPPs are regulated by various regulatory subunits
[15,16].
For both PPP and PPM, metal ions play an important role in
catalysis through the activation of awatermolecule for the dephos-
phorylation reaction. The PPP family is subdivided into type1 (PP1),
type2a (PP2A) and the closely related PP4 and PP6, type PP2B (or
PP3), PP5 andPP7 subgroups (Fig. 2A) [15]. Themembers of thePPM
family are Mn2+/Mg2+ dependent enzymes, such as PP2C and pyru-
vate dehydrogenase phosphatase. The enzymes belonging the PPP
and PPM family dephosphorylate the majority of phospho-serine
and phospho-threonine residues.
The third, most recently classiﬁed group of STPs con-
tains the aspartate-based phosphatases represented by
FCP/SCP (TFIIF-associating component of RNA polymerase II
C-terminal domain CTD phosphatase/small CTD phosphatase),
56 B. Szöör / Molecular & Biochemical Parasitology 173 (2010) 53–63
Table 1
Comparison of the Ser/Thr speciﬁc protein phosphatomes of humans [94] with T. brucei, T. cruzi and L. major [8]. The
catalytic signature motif and metal ions important for enzyme activity are shown.
a
[
and haloacid dehalogenases (HAD) with phosphatase activity
17,18].
In contrast, to the PPP and PPM groups, FCPs/SCPs use an
spartate-based (DxDxT/V) catalytic core todephosphorylatephos-
Table 2
Comparison of the PTP complement [12] in humans and T. b
from Trypanosomatidae are highlighted in white and substrat
The aDSP group includes LRR-DSPs, kinatases, ANK-DSPs, STY
PTPs/ArsC reductaseswere not included in the total number of
to be inactive phosphatases.pho Ser/Thr. The conserved structural core of FCP/SCP is the FCP
homology (FCPH)domain. In addition to this in FCPs, a BRCT (BRCA1
C-terminal domain like) domain is present C-terminal to the FCPH
domain, which is absent from SCPs [17,19].
rucei, T. cruzi and L. major [8]. The PTP classes missing
e speciﬁcity is shown.
Xs, MKP-like and lipid-like phosphatases (Fig. 1). LMW
phosphatases in the kinetoplastids as they are predicted
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.1. STP inhibitors
Through decades of phosphatase research an array of speciﬁc
TP inhibitors have been identiﬁed ﬁrst to classify, then to investi-
ate the physiological role of STPs [20].
In mammalian cells, the cell permeable okadaic acid (OA) is
potent PP2A inhibitor (the 50% inhibitory concentration, IC50:
nM), whereas higher concentrations are necessary to inhibit PP1
IC50: 60–200nM) or PP2B (IC50: 10mM) and PP2C is unaffected by
his inhibitor. In contrast, calyculin A inhibits both PP1 and PP2A,
ut not PP2B or PP2C, with high potency (IC50: 0.5–1nM). Tauto-
ycin is a potent inhibitor of PP1 (IC50: 1nM) and 10 times higher
oncentrations arenecessary to inhibit PP2A (IC50: 10nM),whereas
P2B is weakly inhibited and PP2C is unaffected by this compound
21].
.2. Trypanosomatid STPs
.2.1. PP1
Although protein phosphatase activity was detected in T. brucei
ore than a quarter of a century ago [22] still little is known about
he physiological role of protein phosphatases in kinetoplastids.
he reason for this may be the complicated life cycles of the differ-
nt kinetoplastids (Fig. 1 adapted from Ref. [1]), and the difﬁculties
n culturing and genetic manipulation of the various lifeforms. In
ddition, the TriTryp phosphatome [8] identiﬁed a relatively high
umber of STPs (54/56/58 in T. brucei/T. cruzi/L. major respectively
Supplementary Table 1), compared to 39 in human (Table 1)),
howing high similarity and very likely sharing overlapping roles,
urther complicating functional analysis of these enzymes.
Analysis of TriTryp genomes identiﬁed 8/7/8 (T. brucei/T. cruzi/L.
ajor) PP1s ofwhich 4 in T. brucei, 3 in T. cruzi and 5 in L. majorwere
ound in tandemgene arrays (highlighted in bold in Supplementary
able 1a). The reason for this unique allocation of phosphatase
Table 3
Protein phosphatases characterized in T. brucei, T. cruzi and L. m
The table shows the name, the expression level in the different
(italic) of the characterized enzymes. Abbreviations: Sl, slenderarasitology 173 (2010) 53–63 57
geneshasnotbeen investigated, but itmayhaveevolved to regulate
the differential expression of the different isoforms.
In the early nineties Erondu et al. cloned and characterized two
PP1s (named PP1A (Tb927.8.7390) and B (Tb927.4.5030)) and one
PP4 (Tb11.01.8740) (named PP2A) of T. brucei [23] (Table 3) and
found a remarkable similarity to their mammalian counterparts,
despite the early divergenceof kinetoplastids fromthemainbranch
of eukaryotes [24]. Interestingly the PP1 geneswere co-transcribed
with the gene encoding the RNA polymerase II (RNAPII) largest
subunit [25] and the authors suggested that the RNAPII could be
a substrate for the PP1 in this parasite. Although in multicellular
organisms RNAPII dephosphorylation is mediated by PP1 in vitro,
and probably in vivo, too [26] (in addition to the activity of FCP1),
to date there is no evidence that kinetoplastid PP1 is capable of the
in vivo dephosphorylation of RNAPII.
In the early years of phosphatase research the only tool to iden-
tify the physiological role of the enzymes was the use of speciﬁc
phosphatase inhibitors. The inhibitors,whichwere used previously
to classify Ser/Thr speciﬁc phosphatases in mammalian cells, have
also been used to study the role of STPs in kinetoplastids. When
trypanosomes were treated with OA, the cells were defective in
segregation of the organellar genome and cytokinesis but not in
mitosis, suggesting that the role that protein phosphorylation plays
in cell division may also include a role in the organellar cycle [27].
The available data indicate that these events are coordinated
within the cell cycle [28], although little is still known about the
speciﬁc molecules involved. Since treatment with OA overrides
this coordination, the authors suggested that a proteinphosphatase
might function in the coupling of mitosis and the cell cycle of try-
panosomes. In contrast to the effect of OA, the combined RNAi
ablation of 7 PP1s and the PP2A catalytic subunits in procyclic
forms, resulted in a slow growth phenotype [29] without causing
any severe phenotype or increased number ofmultinucleated cells.
Theexplanation for these conﬂicting reportsmaybe the lackof total
ajor.
life cycle stages (in bold) and the subcellular localization
; St, stumpy; Pcf, procyclic form; ND, not determined.
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blation of the protein phosphatase activities by RNAi, the differ-
nt roles of STPs in different life cycle stages and/or a presence of
nother OA sensitive protein phosphatase in T. brucei. For exam-
le, inhibition of PP1 and PP2A activity by high concentrations of
A (1M) resulted in down-regulation of beta-tubulinmRNA gene
xpression in T. b. rhodesiense [30], although it is not clear the effect
as mediated.
In T. cruzi [31], use of a range of PP1 and PP2A inhibitors
OA, tautomycin (TA) and calyculin A (CA)) demonstrated that
he trypomastigotes treated with low concentrations (1nM) of
A underwent differentiation, spontaneously to generate rounded
mastigote form, and expressed all the markers observed after the
ormal differentiation process. This phenomenon was speciﬁc to
he CA treated cells, suggesting that the CA-sensitive protein phos-
hatase activity, which was detected in the cytoskeletal fraction,
ay play a key role in the remodeling of cell shape, either by
irectly dephosphorylating cytoskeletal proteins, or indirectly, by
ephosphorylating and activating kinases involved in cytoskeleton
hosphorylation, as has been observed in mammalian cells [32].
lso it was noted that, in spite of the similar features of the pH and
A induced transformationof trypomastigotes into amastigote-like
orms, different phosphorylation patterns were observed in each
ase, suggesting that multiple signals may be involved in the regu-
ation of transformation.
Two PP1 isoforms (TcPP1 (Tc00.1047053506201.70) and 
Tc00.1047053507671.39)) were identiﬁed in T. cruzi and the
RNAs were detected in both epimastigote and metacyclic par-
sites by Orr et al. [33] (Table 3). Calyculin A-treated epimastigotes
nderwent ﬂagellar duplication and both kinetoplast and nuclear
ivisions but were incapable of successfully completing cytokine-
is. These cells also lost their characteristic elongated, epimastigote
henotype and adopted a more rounded morphology. The authors
uggested these PP1-like phosphatases are important for the com-
letion of cell division and the maintenance of cell shape in T.
ruzi.
.2.1.1. PP2B/calcineurin. Two distinct types of PP2B were identi-
ed in the TriTryp phosphatome, the ﬁrst group clustered together
ithyeast andvertebrateenzymes,while the secondgroupshowed
ess similarity to other calcineurins [8]. An enzyme with Ca2+
ependent PP2B activity was partially puriﬁed from the cytosol of
eishmania donovani promastigotes (Table 3). This LdPP2B exhib-
ted similar properties to the calcineurins isolated from various
pecies [34]. A novel homologue of PP2B from T. cruzi was also
dentiﬁed and characterized by Moreno et al. [35]. The TcPP2B
Tc00.1047053508413.40) is expressed in all major developmen-
al stages of T. cruzi and it is mainly localized in the cell nucleus
Table 3), in sharp contrast with the mammalian calcineurin A,
hich is mainly found in the cytoplasm and translocates to the
ucleus after binding to its receptor [36]. Out of the four conserved
omains typically present in all calcineurins [37], the TcPP2B has
nly the catalytic and the calcineurin B binding domains and nei-
her the calmodulin-binding, nor the auto-inhibitory domain can
e identiﬁed. Interestingly, after the analysis of the kinetoplastid
P2B amino acid sequences the authors found that only the L. major
alcineurin homologue contained all the four characteristic PP2B
onserved domains described in other species [35].
.2.1.2. PP2A, PP4, PP6. Each TriTryp genome encode two PP2A
soforms, one of which is closely related to yeast and verte-
rate counterparts, while the second is more distant from higher
ukaryote PP2As. The T. cruzi member of the latter group was char-
cterized in an attempt to investigate whether TcPP1 or TcPP2A
Tc00.1047053511021.10) were involved in the transformation of
rypomastigotes into amastigotes [38]. In transformation assays at
H 5.0, even low concentrations (0.1M) of OA had a profoundarasitology 173 (2010) 53–63
effect on the transformation of trypomastigotes while TA, a known
PP1 inhibitor, only had moderate effect (at concentrations up to
10M), suggesting that it is the TcPP2A-type enzymes that are
involved in parasite transformation.
Kinetoplastids have only one isoform of PP4 and PP6, except T.
brucei, which lacks the PP6 homologue (Table 1 and Supplementary
Table 1d and e). The TbPP4 was the ﬁrst novel STP cloned from a
kinetoplastid, although it was referred to as PP2A [23]. To date no
physiological role is known for either PP4 or PP6 in kinetoplastids.
2.2.1.3. PP5. The PP5s are characterized by their N-terminal tetra-
tricopeptide repeat (TPR) domains, with a role in protein–protein
interaction and in auto-inhibition [39]. There is one gene in each
TriTryp genome encoding PP5 (Table 1 and Supplementary Fig. 1f),
but only the TbPP5 (Tb927.10.13670) has been characterized.
This molecule was found in the cytosolic/nuclear fraction of
the cell by Chaudhuri [40]. All the invariant structural motifs (-
GDXHG-, -GDXVXRG- and -GNH-) described in the members of
PPP family [41] were present in TbPP5, as well as in all the T.
brucei STPs characterized to date [8]. The N terminus of TbPP5
contained 3 TPR domains and its activity was stimulated by arachi-
donic acid as described for mammalian PP5 by Chen and Cohen
[42].
The protein level was found to be slightly higher in procyclic
forms compared to bloodstream forms (Table 3) and the tran-
script level decreased in cells transferred from the logarithmic
phase growth to the stationary phase in culture. In procyclic
cells, following 18h starvation, the transcript level of TbPP5 was
reduced approx 3-fold, suggesting a role for this phosphatase in
the active growth phase of the parasite. Through its TPR motifs,
PP5 interacts with various stress-related proteins including Hsp90
in other eukaryotes [43]. In T. brucei, an essential Hsp90 homo-
logue (TbHsp83) with reasonably high similarity to its vertebrate
counterpart and very high ATPase activity was identiﬁed [44].
Recently, it was shown that TbHsp83 interacts with TbPP5 in vivo
andboth TbPP5 and TbHsp83 accumulate in thenucleus duringpro-
teotoxic stresses [45]. Theauthors showed thatboth inbloodstream
and procyclic forms over-expressing TbPP5 reduced, and ablation
of TbPP5 increased, the growth inhibitory effect of the speciﬁc
Hsp90 inhibitor geldanamycin. This effect was more pronounced
in bloodstream form compared to procyclics, suggesting that TbPP5
may be involved in regulating Hsp90 function under stress, either
increasing the chaperon function of TbHsp83 via stabilizing the
TbHsp83–substrate complex or maintaining the dephosphorylated
state of TbHsp83 [45].
2.2.1.4. PP7/PPEF (protein phosphatases with EF-hand). The PP7
group shows sequence similarity to PP5, but they are regulated
by a calmodulin-binding domain at the N-terminal, and the Ca2+
binding EF-hand motifs at the C-terminal regions of the molecule.
There are two PP7 in T. brucei and T. cruzi, but only one
gene was identiﬁed in L. major [46] (Table 1 and Supplementary
Table 1g). In kinetoplastids the members of the PPEF family do
not have a calmodulin-binding motif and their EF-hand motifs
differ from the consensus. Because of the missing calmodulin-
binding domain, and the modiﬁed EF-hand, these enzymes are
unlikely to be regulated by Ca2+, although this has not yet been
tested. L. major PPEF (LmPPEF (LmjF12.0660)) is myristoylated and
palmitoylated and expressed throughout the life cycle. In vivo
the protein is localized in the endomembrane system and in the
ﬂagellar pocket. Acylation appears to be sufﬁcient for targeting
LmPPEF to the ﬂagellar pocket but not for endomembrane local-
ization. Down-regulation of TbPPEF (Tb927.1.4050) protein levels
by RNAi in T. brucei results in a partial growth inhibition caused
by the decreased level of the enzyme, but the authors suggested
a total loss of PPEF activity might cause a more dramatic pheno-
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ype. The authors propose a functional, although different roles
rom other PPEF/RdgC molecules described in multicellular organ-
sms.
.2.1.5. Shewanella-like (Shelps), ApaH-like (Alphs) phosphatases and
inetoplastid STPs (kSTPs). Proteinphosphatases showing similarity
o bacterial phosphatase-like enzymes were described in various
ni- and multicellular organisms (kinetoplasts, plants, diatoms,
ungi, tunicate) suggesting these enzymeswerepresent in common
ncestor of eukaryotes, but were lost in insects, vertebrates and
owering plants amongst other taxons [47]. These protein phos-
hatases have an (I/L/V)D(S/T/G) motif which may have a role in
ltering the substrate speciﬁcity of these enzymes.
Both Alphs and Shelps are present in kinetoplastids and
lthough the 3D structure of a T. brucei Alph was recently resolved,
o physiological role or substrate speciﬁcity was described for this
roup [48].
The rest of the PPPs in this group (kSTPs) carry mutations in cat-
lytically important regions of the enzymes, and form a large group
f kinetoplastid speciﬁc phosphatases with some similarity to
lant and fungal protein phosphatases. These pseudophosphatases
ight act as natural “substrate trapping mutants” binding to
hosphosubstrates and shielding from being dephosphorylated by
ctivephosphatases. Alsowhile someof thesepseudophosphatases
ack protein phosphatase activity, they might have retained or
ained other type of enzymatic activity or solely act as scaffolding
olecules.
.2.2. PPM/PP2C
The PPM family of kinetoplastids show higher similarity to
uman and yeast PPM [8] than to their expanded plant counter-
arts [49]. The phosphatase activity of the PPMs depends on Mg2+
nd Mn2+, and a set of 11 conserved motifs has been identiﬁed
ithin this family [50].
From Leishmania chagasi, LcPP2C was cloned and characterized
y Burns et al. [51]. The enzyme was present in both infective
romastigote and tissue amastigote stages of L. chagasi and amazo-
ensis. Surprisingly, the enzymatic characteristics of LcPP2C were
emarkably similar to mammalian PP2C despite of the relative low
equence identity (30%) between these enzymes.
.2.3. FCP phosphatases
FCPs use aspartate-based catalysis to hydrolyze phosphoesther
onds and, in yeast and multicellular organisms, dephosphorylate
he carboxy terminal domain (CTD) of RNA polymerase II (RNAPII).
his induces interaction with TFIIF [52] and promotes recycling of
NAPII after transcription. The canonical CTD is essential for gene
xpression inmetazoaandyeast andcharacterizedbyheptapeptide
YSPTSPS) repeats.
Many organisms, including trypanosomes, lack a canonical CTD
nd in these species the CTD is called a non-canonical CTD or
seudo-CTD. In kinetoplastids, despite the lack of the conserved
eptad repeats of the CTD of RNAPII, phosphorylation has been
etected in the so-called pseudo-CTD domain, although no CTD
hosphatase was yet identiﬁed to dephosphorylate these residues
53]. There is an expansion of the FCP1 family in kinetoplastids
ompared to humans (Table 1), as yet, none of them was so far
haracterized as a CTD phosphatase.
The ﬁrst phosphatase containing a DxDxT motif, characteristic
o FCP phosphatases, was identiﬁed recently [54] in a substrate
rapping experiment [55]. The differentiation regulator tyrosine
hosphatase TbPTP1 [56] was used as bait, in an attempt to ﬁnd
he downstream regulators of differentiation.
The identiﬁed phosphatase interacting protein with
9kDa molecular weight (TbPIP39A&B (Tb09.160.4460 and
b09.160.4480)) was upregulated in procyclic forms, and targetedarasitology 173 (2010) 53–63 59
to the glycosome via a C-terminal peroxisomal targeting signal. It
was found that the divalent cation dependent DxDxT phosphatase
TbPIP39 forms a complex with TbPTP1, the latter’s activity being
stimulated by TbPIP39, this being prevented by the differential
triggers citrate/cis aconitate.
To date this is the ﬁrst evidence of a signaling cascade that is
directed to glycosomes (or indeed any peroxisome type organelles)
andmay lead to further understanding the evolution of peroxisome
biogenesis and function [57].
3. Protein tyrosine phosphatases (PTPs)
PTPs share a common signature motif (CX5R) and can be clas-
siﬁed into 4 main groups according to their catalytic domains and
their substrate speciﬁcity.
The largest group in vertebrates is the cysteine (Cys) based Type
I group (Fig. 2B and Table 2), which can be subdivided into Classical
andDual SpeciﬁcityPhosphatases (DSPs) [12]. The classical PTPsare
classiﬁed, dependingon thepresenceor absenceof transmembrane
domains, into receptor or non-receptor type phosphatase groups.
The DSP groups form the largest and most diverse family of
Cys based phosphatases. Members of this family dephosphorylate
a wide variety of phosphosubstrates in addition to phosphoTyr
and have been classiﬁed into seven subgroups [12]: MAP kinase
phosphatases (MKPs), atypical DSPs, Slingshots, phosphatases of
the regenerating liver (PRL), CDC14s and the members of the
two classes which can dephosphorylate phospholipids-PTEN and
myotubularins (Fig. 2B and Table 2).
The class II of PTPs contains the low molecular weight phos-
phatase (LMW PTP).
The third group of PTPs (class III) is the CDC25 family; these
enzymes are both tyrosine and threonine speciﬁc, dephosphorylate
cyclin dependent kinases [58], which show similarity to bacterial
arsenate reductases and also have rhodanese-like domains. The
rhodanese domains were ﬁrst described in rhodaneses, enzymes
catalyzing the transfer of a sulfane sulfur atom from thiosulfate to
cyanide in vitro. The most relevant structural difference between
rhodanese and Cdc25 enzymes is the length of the active-site loop,
which in Cdc25 proteins is formed by seven residues instead of
the six in sulfurtransferases; this results in a wider catalytic pocket
that can accommodate a phosphorous atom,which is slightly larger
than a sulfur atom [59].
The fourth PTP family comprises the EyA (eyes absent) tyro-
sine phosphatases, ﬁrst characterized as a novel nuclear protein
required for eye development in Drosophila and the heterogeneous
family of haloacid dehalogenase (HAD) enzymes, which exhibit a
wide substrate speciﬁcity dephosphorylating phospholipids, sug-
ars, nucleotides and tyrosine or serine phosphorylatedproteins and
have been found only in multicellular organisms to date (reviewed
in Refs. [60,61]).
3.1. Kinetoplastid tyrosine phosphatases
3.1.1. Kinetoplastid phosphatase activities
The characterization of PTPs has lagged behind that of STPs in
kinetoplastids (eleven vs. four enzymes see (Table 3)), perhaps
caused by the lack of speciﬁc, permeable inhibitors against the
different classes of PTPs. Until recently, vanadate and its deriva-
tives were the only tools available to address physiological roles of
tyrosine phosphatases, preventing the identiﬁcation of PTP genes
responsible for the measured tyrosine phosphatase activity.
Although the TriTryp kinome does not contain bona ﬁde
tyrosine kinases [7], tyrosine phosphorylation is detected and
extent of phosphorylation differs in the tractable life cycle
stages in T. brucei [62]. In L. donovani tyrosine phosphatase
activitywas also detected [63] suggesting that tyrosine phosphory-
lation occurs, though not via receptor tyrosine kinase and tyrosine
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inase like kinase activities but very likely due to the activity of
typical and/or dual speciﬁc kinases.
.1.2. Membrane-bound PTP activities
Unicellular organisms, including kinetoplastids do not have any
eceptor type PTPs with transmembrane domains, which means
hat the gene encoding a life cycle speciﬁc membrane-bound pro-
ein tyrosine phosphatase activity identiﬁed in T. brucei [64] likely
o have either a signal, which localizes the protein to membra-
ous subcellular compartments, or be a member of a membrane
ound complex. In reconstitution experiments on bloodstream
orm membrane proteins, 3 proteins (148, 115 and 72kDa) exhib-
ted PTP activity this being abolished upon vanadate treatment.
o corresponding tyrosine phosphatases were present in procyclic
orms.
Another membrane-bound PTP has been described in L. major
etacyclic promastigote forms, which is translocated to the cyto-
lasm in promastigotes [65]. The authors raised two antibodies
gainst the catalytic domains of the human placental PTP1B and
PTP from T. brucei, which cross-reacted with a 55–60kDa protein
resent in the soluble detergent-extracted fraction of a Leishmania
omogenate. In spite of the increased level of themolecule inmeta-
yclic promastigotes compared to the procyclic forms, the speciﬁc
ctivity of the enzyme was lower in metacyclic than in procyclic
romastigotes.
.1.3. Ectophosphatases
The ﬁrst a membrane bound ectophosphatase with tyrosine
hosphatase activity, which is upregulated in T. brucei bloodstream
orms was cloned by Bakalara et al. [66]. To date no physio-
ogical role was allocated to ectophosphatases, however, several
ypotheses have been suggested roles in protection from cytolytic
ffects of extracellular ATP, dephosphorylation of ectokinase or
ost organism kinase substrates or involvement in signal trans-
uction and regulating cellular adhesion (reviewed in Ref. [67]).
lthough some ectophosphatase can dephosphorylate tyrosine-
hosphorylated substrates [67,68] they do not show any sequence
imilarity to PTP or STPs and for this reason they were excluded
rom this review.
.1.4. Cytosolic PTP activities
Bakalara et al. [69] described life cycle stage speciﬁc tyrosine
hosphatase activities in T. cruzi and in T. brucei. Interestingly,
he PTP activity of the lysates of the non-dividing parasites (try-
omastigotes in T. cruzi) had a different pH optimum (pH 5.0)
ompared to dividing cell (epimastigotes in T. cruzi and blood-
tream and procyclic forms in T. brucei) lysate, which showed the
ighest PTP activity at pH 7.0. The authors also showed that the
yrosine phosphatase activity in T. brucei procyclic forms was less
han 60% of the activity measured in bloodstream forms, which
ccording to the authors might suggest different roles for the tyro-
ine phosphatases in the different life cycle stages.
In vivo experiments in mice also showed that inhibition of PTP
ctivities can lead to a complete block of the development of cuta-
eous lesions, almost complete disappearance of parasites from
opliteal lymph nodes and a reduction of the liver parasite load
t two weeks post-treatment.
.2. Class I classical PTPs
.2.1. Non-receptor PTPs
Based on the 10 conserved motifs described in other eukary-
tes [70] the kinetoplastid PTPs can be divided into three groups
8]. The members of the group 1 are LmPTP1 (LmjF36.5370), and
ts orthologue in T. cruzi TcPTP1 (Tc00.1047053506839.60), which
how the highest similarity to vertebrate PTP1B throughout the 10arasitology 173 (2010) 53–63
conserveddomains, interestingly theT. bruceiorthologue ismissing
from this group (Table 2 and Supplementary Table 2a highlighted
in bold).
The second group of PTPs lacks the motif 2 (DX2RVXL), which
is replaced by a kinetoplastid speciﬁc domain [56] and is repre-
sented in all three kinetoplastid genomes. This group comprises
TbPTP1 (Tb10.70.0070, which is despite of its name not an ortho-
logue of LmPTP1), TcPTP2 (Tc00.1047053510187.234) and LmPTP2
(LmjF36.2180).
The third group shows less similarity to the conserved motifs of
mammalian PTP1B, and its members are only present in T. brucei
and L. major (Supplementary Table 2a, highlighted in italic). These
kinetoplastid PTPs carry substitutions in motifs 2–7 and an addi-
tional deletion between motifs 7 and 8, resulting in a PTP domain
with decreased stability.
Enzymes of the ﬁrst group and their role in vivowas investigated
in Leishmania, where the enzyme was deleted by gene targeting,
revealing that LPTP1 is necessary for survival as amastigotes in
mice, but dispensable for survival as promastigotes in culture [71].
Morphologically, the LdPTP1mutant promastigoteswere similar to
wild type parasites. However, the LdPTP1 mutants were severely
attenuated in comparison to the wild type L. donovani with respect
to survival in the liver and spleen of BALB/c mice.
The ﬁrst PTP1 of group 2 was identiﬁed and characterized by
our group [56]. We showed that the inactivation of the cytosolic
TbPTP1 in bloodstream trypanosomes by RNA interference, or
a PTP1B speciﬁc inhibitor 3-(3,5-dibromo-4-hydroxy-benzoyl)-
2-ethyl-benzofuran-6-sulfonicacid-(4-(thiazol-2-ylsulfamyl)-
phenyl)-amide (BZ3), triggered spontaneous differentiation to
procyclic forms in a subset of cells committed to differentiate.
In homogeneous populations of stumpy forms, pharmacological
inhibition of TbPTP1 caused, cells to synchronously differentiate
to procyclic forms, suggesting an important role for TbPTP1 pre-
venting differentiation to procyclic forms in the bloodstream. In an
attempt to further characterize the TbPTP1 signaling cascade our
group recently identiﬁed an interacting partner/substrate of the
TbPTP1 (TbPIP39) which proven to be a DxDxT phosphatase [54]
and described in Section 2 of this review. While this review was
in preparation, a research group published the resolved crystal
structure of TbPTP1 [72] and showed high structural conserva-
tion of the conventional PTP fold despite of the relatively low
(24%) sequence identity to the closest TbPTP1 homologue, the
human PTP1. The same group also identiﬁed the nuclear RNA
binding NOPP44/46 [73] as a substrate for TbPTP1 in procyclic
forms.
The two closest homologues of TbPTP1 (Tb10.70.0070), were
characterized and named by our group: TbPTP2 (Tb.11.01.5450)
[54,74] and TbPTP3 (Tb09.v1.0350) [74]. The TbPTP2 belongs to
the kinetoplastid DSP group and the sequence analysis of TbPTP3
revealed the closest similarity to other lipid-like dual speciﬁc phos-
phatases. Although TbPTP1, TbPTP2 and TbPTP3 belong to the class
I cysteine-based PTPs, we suggest different roles for these phos-
phatases, as ablation of each gene by RNAi resulted in different and
distinct phenotypes [56,74].
3.2.2. Dual speciﬁc phosphatases (DSPs)
In kinetoplastids the DSP family is the largest group of
phosphatases (19/21/23 T. brucei/T. cruzi/L. major respectively,
Supplementary Table 2b–i) containing a wide variety of phos-
phatases, which can be subgrouped into two groups based on
domain structure and sequence homology [8]. The eukaryoticDSP
(eDSPs) group, is made up of DSPs showing good conservation of
classicalDSP-speciﬁcdomains (SupplementaryTable2b–c) [75,61],
while the phosphatases in the second, atypical DSP (aDSP) group,
show low similarity to eukaryote DSPs, with unusual domain orga-
nization and catalytic core (Supplementary Table 2c–g) [8].
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.2.2.1. EukaryoticDSPs: phosphatases of the regenerating liver (PRL)
nd CDC14s. PRL: The PRLs are closely related to the Cdc14s and
TENs and located on various intracellularmembranes. All PRLs are
arnesylated, carrying a C-terminal CAAX motif, and play a role in
egulating proliferation, migration and invasion of epithelial cells
76]. PRLs are not expressed in all eukaryotes and absent from the
ajority of protists. In kinetoplastids all the PRLs (1/4/2 in Tb/Tc/Lm
Supplementary Table 2b)) [8], contain the C-terminal prenylation
ignal, and one of these enzymes has been characterized from T.
ruzi [77]. This enzyme, TcPRL-1 (Tc00.1047053503851.24) is far-
esylated in the C-terminal region, which proved to be necessary
or the protein subcellular localization in the endocytic pathway of
. cruzi.
CDC14s: CDC14 phosphatases are related to the class III CDC25
hosphatases, and dephosphorylate cyclin dependent kinases
CDK), which regulate exit of mitosis and cell and centrosome divi-
ion [78]. One Cdc14 orthologue was identiﬁed in each TriTryp
enome (Table 2 and Supplementary Table 2c), and although none
f them have been characterized, based on their important role in
east, an essential role is likely in kinetoplastids, also.
.2.2.2. Atypical DSPs (aDSPs). aDSPs, the most varied group of
SPs, share some characteristics of MKPs but they lack the rho-
anese homology domains and can be divided into 4 groups
8].
The members of the ﬁrst group (Fig. 2 and Supplementary Table
d) carry additional domains involved in possible protein–protein
nteraction in addition to the DSP catalytic domain: (i) LRR-DSPs
ave additional Leucine Rich Repeats (LRR), the (ii) kinatases have
RR and pseudokinase domains, and ﬁnally the (iii) sole T. cruzi
NK-DSP has an ankyrin repeat. None of the members of this group
ave been characterized, but they showgoodhomology to bacterial
roteins with LRR motifs annotated as small GTP-binding proteins
8] suggesting a possible similar role in kinetoplastids, acting as
caffold proteins in signaling cascades.
The members of the second group of aDSPs are inactive and
elong to the family of STYX phosphatases (Supplementary Table
e). In other organisms these inactive enzymes are reported to act
s modulators of signaling processes, via binding and controlling
ubcellular localization of phosphosubstrates [79].
MKPs have a conserved inactive rhodanese homology domain
nd can simultaneously dephosphorylate the Thr andTyr of the TXY
otif in MAPKs. Although the MKPs show little sequence homol-
gy to the classical PTPs, they share similar 3D structure around the
atalytic sites of the enzymes [80]. In kinetoplastids no MKP ortho-
ogues of the human proteins were found (Table 2), but some of the
inetoplastid MKP-like phosphatases (Fig. 1 and Supplementary
able 2f), belonging to the third group of aDSPs, show similarity
o plant MKPs [8] suggesting potentially conserved roles.
The lipid-like DSPs form the fourth group of aDSPs
Supplementary Table 2g); these enzymes have various mutations
n the catalytic P-loop and show low homology to the classical
SP domains. Some of these enzymes show similarity to the
atalytic core of the triple speciﬁc phosphatase MptpB [81] sug-
esting a similar type of substrate speciﬁcity for the kinetoplastid
rthologues.
.2.2.3. Lipid phosphatases: phosphatase and tensin homologue
eleted on chromosome 10 (PTENs) and myotubularins (MTMs). The
embers of these families dephosphorylate phospholipids and act
s tumor suppressors (PTEN) and regulators of endosomal trafﬁck-
ng (MTM) in addition to having a role in many critical signaling
ascades (Supplementary Table 2h) [48,75].
PTENs were identiﬁed in the phosphatome of all three kineto-
lastids, and group into two families based upon their sequence
omology to other eukaryote PTENs (eukaryotic like and kineto-arasitology 173 (2010) 53–63 61
plastid like PTENs). Interestingly T. cruzi have four and L. major 1
eukaryotic like PTENs, while no T. brucei orthologue was identiﬁed.
Eachof the threekinetoplastids alsohasonekinetoplastid likePTEN
enzyme (Table 2 and highlighted in bold in Supplementary Table
2h).
In vertebrates the MTMs are relatively large enzymes (from 450
to over 1000 amino acids), and they form the largest group of
DSPs (16 in humans). Although in kinetoplastids the size of these
enzymes are even bigger than the mammalian enzymes (from 800
to over 3000 amino acids), with long N-terminal extensions, the
number of enzymes is reduced to twoMTMs in each genomes, with
no described functions in any of the kinetoplastids.
3.2.2.4. Kinetoplastid DSP. This group contains several kinetoplas-
tid speciﬁc DSPs (11/9/11) (Table 2 and Supplementary Table 2i),
without known function. The members of this group exhibit most
of the DSP motifs, but show no close homology to any of the other
groups of the DSPs in other species.
3.2.2.5. Slingshots. Slingshots show some similarity in their struc-
ture to DSPs, and were ﬁrst identiﬁed in Drosophila [82]. These
enzymes dephosphorylate serine phosphorylated proteins of the
actin-depolymerisation factor (ADF)/coﬁlin group. Themammalian
counterparts of the enzymes contain a 14-3-3 binding motif, a C-
terminal F-actin binding site and an SH3 binding motif [83] in
addition to the PTP catalytic core. In protists no obvious homo-
logues of Slingshots were identiﬁed (Fig. 2 and Table 2).
3.3. Class II: low molecular weight phosphatase (LMW)/arsenate
reductases (ArsC)
In vertebrates, the solemember of this family dephosphorylates
tyrosine-phosphorylated substrates and is related to lowmolecular
weight bacterial rhodanese-likephosphatases [84]. The LMWphos-
phatases in animals regulate cell growth, mainly by counteracting
signaling from various growth factor receptors [85]. Interestingly,
all the kinetoplastid LMW PTP (Supplementary Table 2j) lack their
catalytic Cys residue in the active site suggesting these enzymes
might be inactive.
3.4. Class III: cell divison cycle 25 phosphatases (Cdc25)/ARC2
Cdc25phosphatasesareabundant inallmulticellularorganisms,
with a role of dephosphorylating and activating cyclin dependent
kinases (CDK). In the TriTryp kinome, several CDK like kinaseswere
identiﬁed, and the cell cycle has been shown to be regulated by
these enzymes [86].
In L. donovani and L. major promastigotes a vanadate compound
(bpV-potassium bisperoxo(1,10-phenantroline)oxovanadate Vi)
caused time and concentration dependent inhibition of phos-
phatase activity, resulting in an increase of cells arrested in G2/M
phase of the cell cycle [87]. Upon inhibition also hyper phospho-
rylation of CDK1 was also observed, identifying this kinase as a
possible in vivo substrate, as described in mammalian cells [88,89]
suggesting an important role of CDC25-like phosphatases in these
kinetoplastids.
Interestingly, no CDC25 homologue was found in T. brucei
(Table 2 and Supplementary Table 2k), which might suggest
that cell cycle regulation is regulated by another DSP(s) in
T. brucei.
The CDC25-like member of this family, LmARC2 (LmjF32.2740)
was described as a metalloid reductase by Zhou et al. [90] and later
identiﬁed as a tyrosine phosphatase [91]. In addition to its in vitro
phosphatase activity, the enzyme is able to reduce both As(V) and
Sb(V) and is involved in the activationof pentostam, a drug contain-
ing Sb(V) used in the treatment of leishmaniasis. Mukhopadhyay
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t al. [92] in their recent paper resolved and characterized the 3D
tructure of LmARC2, and showed that the enzyme possesses a
nique catalytic site, and does not belong to either the classical
DC25 group, or the As/Sb reductases but rather an enzyme with
ifunctional ability to dephosphorylate phosphosubstrates and to
educe As/Sb in kinetoplastids.
. Concluding remarks
The completed genome projects of the 5 kinetoplastids species
ade possible to assemble the kinome and phosphatome of these
arasites and proved to be a powerful tool to systematically inves-
igate the predicted functions of enzymes involved in control of
rotein phosphorylation–dephosphorylation.
The TriTryp phosphatome provided valuable information,
howing a reduction in number of the PTPs (107 human PTPs vs.
4/30/30 T. brucei/T. cruzi/L. major respectively) (Table 2) which
oincides with the lack of tyrosine speciﬁc protein kinases in kine-
oplastids [7]. Interestingly, the increased number of atypical STPs
nd DSPs, in addition to the expansion of the STP family seem-
ngly balances the total loss of receptor tyrosine phosphatases,
APK and Slingshot families and reducednumbers of non-receptor
TPs and PPMs (Tables 2 and 3). Interestingly not expansion, but
ather reduction of the phosphatome was described in Plasmod-
um falciparum according to the recently published work on the
hosphatome of the human malaria parasite [93].
In addition to the high number of Kinetoplastid speciﬁc phos-
hatases the number of PP1s has been increased (3 human vs.
/7/8), by gene duplication. The roles of the seemingly high number
f these highly similar genes are far from fully understood.
The comparative analysis of the kinetoplastid phosphatomes
hows interesting differences, which may be attributed to the dif-
erent living environments of the parasites. T. brucei, the only
xtracellular parasite of the 5 kinetoplastids investigated, has an
nique and smaller phosphatome compared to the intracellular T.
ruzi and Leishmania ssp.
As it is shown in this review, despite of the vast amount of in
ilico data, there is still relatively little known about the in vivo
unction, substrate speciﬁcity and regulation of the kinetoplas-
id protein phosphatases (Table 3). To resolve this contradiction,
n the future in vivo functional examinations need to be carried
ut. Combining methods of genetic manipulations, high through-
ut proteomics and use of speciﬁc inhibitors, with the in silico data
hould be a rational approach to further understand the regulation
f signal transduction in kinetoplastids.
As the kinetoplastids phosphatase genes show low similarity
o their vertebrate counterparts, targeting essential kinetoplastid
rotein phosphatases may be a feasible strategy to ﬁght these
athogens, and the diseases caused by them, without interfering
ith the host organism signaling networks.
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